While glucagon historically raised concerns because it elevates blood sugar, the combination with GLP-1 activity shifts the effect toward increased energy expenditure rather than hyperglycemia
That risk differential increased to 14 percent a year after they stopped a GLP-1, and rose to as much as 22 percent after two years off the medication
Among participants who completed 12 weeks without discontinuing, 87% went on to achieve at least 15% weight loss by the end of the study
So, you would use a smaller, more precise syringe (like an insulin syringe) to draw exactly 0.2 mL from the vial for your experiment
Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study
Although it was approved in 1994, its still a first-choice treatment for diabetes, says Michelle Ponder, MD, an endocrinologist and assistant professor of medicine at Duke University